| 1401 |
Cord Tissue |
Allogeneic – Unrelated |
Leukodystrophy |
Neurology |
2024 |
Experimental Therapy |
Poland |
1,9 |
| 1402 |
Cord Tissue |
Allogeneic – Unrelated |
Cerebral Palsy |
Neurology |
2024 |
Experimental Therapy |
Poland |
4,5 |
| 1403 |
Cord Blood |
Autologous |
Autism |
Neurology |
2024 |
Experimental Therapy |
Romania |
11 |
| 1404 |
Cord Blood |
Autologous |
Autism |
Neurology |
2024 |
Experimental Therapy |
Romania |
10 |
| 1405 |
Cord Blood |
Autologous |
Autism |
Neurology |
2024 |
Experimental Therapy |
Romania |
6 |
| 1406 |
Cord Blood |
Autologous |
Autism |
Neurology |
2024 |
Experimental Therapy |
Romania |
4 |
| 1407 |
Cord Blood |
Autologous |
Autism |
Neurology |
2024 |
Experimental Therapy |
Romania |
5 |
| 1408 |
Cord Blood |
Allogeneic |
Cerebral Palsy |
Neurology |
2024 |
Experimental Therapy |
Poland |
3,5 |
| 1409 |
Cord Blood |
Allogeneic |
Cerebral Palsy |
Neurology |
2024 |
Experimental Therapy |
Poland |
7,7 |
| 1410 |
Cord Blood |
Autologous |
CP |
Neurology |
2024 |
Experimental Therapy |
Hungary |
4 |
| 1411 |
Cord Blood |
Autologous |
Pervasive Developmental Disorder |
Neurology |
2024 |
Experimental Therapy |
Poland |
3,7 |
| 1412 |
Cord Blood |
Autologous |
Pervasive Developmental Disorder |
Neurology |
2024 |
Experimental Therapy |
Poland |
5,9 |
| 1413 |
Cord Blood |
Autologous |
Pervasive developmental disorder |
Neurology |
2024 |
Experimental Therapy |
Poland |
4,8 |
| 1414 |
Cord Blood |
Allogeneic – Related |
fanconi aplastic anemia |
Hematology |
2024 |
Standard Therapy |
Turkey |
12 |
| 1415 |
Cord Blood |
Autologous |
Neuroblastoma |
Neurology |
2024 |
Standard Therapy |
Poland |
4 |
| 1416 |
Cord Blood |
Autologous |
Pervasive developmental disorder |
Neurology |
2024 |
Experimental Therapy |
Poland |
9,9 |
| 1417 |
Cord Blood |
Autologous |
Autism |
Neurology |
2024 |
Experimental Therapy |
Slovakia |
4 |
| 1418 |
Bone Marrow Family |
Allogeneic |
Acute Myelogenous Leukemia |
Hematology |
2024 |
Standard Therapy |
Poland |
69 |
| 1419 |
Bone Marrow Family |
Allogeneic |
Acute Myelogenous Leukemia |
Hematology |
2024 |
Standard Therapy |
Poland |
70 |
| 1420 |
Bone Marrow Family |
Allogeneic |
Acute Myelogenous Leukemia |
Hematology |
2024 |
Standard Therapy |
Poland |
75 |
| 1421 |
Bone Marrow Family |
Allogeneic |
Acute Myelogenous Leukemia |
Hematology |
2024 |
Standard Therapy |
Poland |
56 |
| 1422 |
Bone Marrow Family |
Allogeneic |
Acute Myelogenous Leukemia |
Hematology |
2024 |
Standard Therapy |
Poland |
23 |
| 1423 |
Bone Marrow Family |
Allogeneic |
Acute Myelogenous Leukemia |
Hematology |
2024 |
Standard Therapy |
Poland |
54 |
| 1424 |
Bone Marrow Family |
Allogeneic |
Acute Myelogenous Leukemia |
Hematology |
2024 |
Standard Therapy |
Poland |
69 |
| 1425 |
Bone Marrow Family |
Allogeneic |
Acute Myelogenous Leukemia |
Hematology |
2024 |
Standard Therapy |
Poland |
70 |
| 1426 |
Bone Marrow Family |
Allogeneic |
Acute Myelogenous Leukemia |
Hematology |
2024 |
Standard Therapy |
Poland |
65 |
| 1427 |
Bone Marrow Family |
Allogeneic |
Acute Myelogenous Leukemia |
Hematology |
2024 |
Standard Therapy |
Poland |
48 |
| 1428 |
Bone Marrow Family |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2024 |
Standard Therapy |
Germany |
72 |
| 1429 |
Bone Marrow Family |
Allogeneic |
Chronic Lymphocytic Leukemia Richter Transformation |
Hematology |
2024 |
Standard Therapy |
Poland |
55 |
| 1430 |
Bone Marrow Family |
Allogeneic |
Chronic Myelogenous Leukemia |
Hematology |
2024 |
Standard Therapy |
Poland |
63 |
| 1431 |
Bone Marrow Family |
Allogeneic |
Follicular Lymphoma |
Hematology |
2024 |
Standard Therapy |
Poland |
48 |
| 1432 |
Bone Marrow Family |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2024 |
Standard Therapy |
Poland |
65 |
| 1433 |
Bone Marrow Family |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2024 |
Standard Therapy |
Germany |
58 |
| 1434 |
Bone Marrow Family |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2024 |
Standard Therapy |
Poland |
70 |
| 1435 |
Bone Marrow Family |
Allogeneic |
Myelodysplastic Syndrome – Refractory Cytopenia Of Childhood |
Hematology |
2024 |
Standard Therapy |
Poland |
14 |
| 1436 |
Bone Marrow Family |
Allogeneic |
Myelodysplastic Syndrome/ Myeloproliferative Neoplasms |
Hematology |
2024 |
Standard Therapy |
Germany |
61 |
| 1437 |
Bone Marrow Family |
Allogeneic |
Myelodysplastic Syndrome-MPN |
Hematology |
2024 |
Standard Therapy |
Poland |
71 |
| 1438 |
Bone Marrow Family |
Allogeneic |
Myelofibrosis |
Hematology |
2024 |
Standard Therapy |
Poland |
68 |
| 1439 |
Bone Marrow Family |
Allogeneic |
Non-Hodgkin Lymphoma |
Hematology |
2024 |
Standard Therapy |
Poland |
64 |
| 1440 |
Bone Marrow Family |
Allogeneic |
Polycythemia Vera/Myelofibrosis |
Hematology |
2024 |
Standard Therapy |
Poland |
74 |
| 1441 |
Bone Marrow Family |
Allogeneic |
Primary Myelofibrosis |
Hematology |
2024 |
Standard Therapy |
Germany |
62 |
| 1442 |
Bone Marrow Family |
Allogeneic |
Acute Myelogenous Leukemia |
Hematology |
2024 |
Standard Therapy |
Poland |
68 |
| 1443 |
Bone Marrow Family |
Allogeneic |
Myelodysplasia |
Hematology |
2024 |
Standard Therapy |
United Kingdom |
57 |
| 1444 |
Bone Marrow Family |
Allogeneic |
Acute Myelogenous Leukemia |
Hematology |
2024 |
Standard Therapy |
Germany |
69 |
| 1445 |
Bone Marrow Family |
Allogeneic |
Acute Myelogenous Leukemia |
Hematology |
2024 |
Standard Therapy |
USA |
58 |
| 1446 |
Bone Marrow Family |
Allogeneic |
Acute Myelogenous Leukemia |
Hematology |
2024 |
Standard Therapy |
USA |
60 |
| 1447 |
Bone Marrow Family |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2024 |
Standard Therapy |
Poland |
71 |
| 1448 |
Bone Marrow Family |
Allogeneic |
High risk Myelodysplastic Syndrome |
Hematology |
2024 |
Standard Therapy |
Germany |
69 |
| 1449 |
Bone Marrow Family |
Allogeneic |
Acute Myelogenous Leukemia |
Hematology |
2024 |
Standard Therapy |
USA |
74 |
| 1450 |
Bone Marrow |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2024 |
Standard Therapy |
Poland |
15 |
| 1451 |
Bone Marrow |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2024 |
Standard Therapy |
Poland |
8 |
| 1452 |
Bone Marrow |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2024 |
Standard Therapy |
Poland |
12 |
| 1453 |
Bone Marrow |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2024 |
Standard Therapy |
Poland |
8 |
| 1454 |
Bone Marrow |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2024 |
Standard Therapy |
Poland |
52 |
| 1455 |
Bone Marrow |
Allogeneic |
Acute Myelogenous Leukemia |
Hematology |
2024 |
Standard Therapy |
Poland |
57 |
| 1456 |
Bone Marrow |
Allogeneic |
Acute Myelogenous Leukemia |
Hematology |
2024 |
Standard Therapy |
Poland |
66 |
| 1457 |
Bone Marrow |
Allogeneic |
Acute Myelogenous Leukemia |
Hematology |
2024 |
Standard Therapy |
Poland |
5 |
| 1458 |
Bone Marrow |
Allogeneic |
Acute Myelogenous Leukemia |
Hematology |
2024 |
Standard Therapy |
Poland |
54 |
| 1459 |
Bone Marrow |
Allogeneic |
Acute Myelogenous Leukemia |
Hematology |
2024 |
Standard Therapy |
Poland |
56 |
| 1460 |
Bone Marrow |
Allogeneic |
Acute Myelogenous Leukemia |
Hematology |
2024 |
Standard Therapy |
Poland |
3 |
| 1461 |
Bone Marrow |
Allogeneic |
Adrenoleukodystrophy |
Hematology |
2024 |
Standard Therapy |
Poland |
7 |
| 1462 |
Bone Marrow |
Allogeneic |
Adrenoleukodystrophy |
Hematology |
2024 |
Standard Therapy |
Poland |
7 |
| 1463 |
Bone Marrow |
Allogeneic |
Adrenoleukodystrophy |
Hematology |
2024 |
Standard Therapy |
Poland |
9 |
| 1464 |
Bone Marrow |
Allogeneic |
B-Acute Lymphoblastic Leukemia |
Hematology |
2024 |
Standard Therapy |
Poland |
7 |
| 1465 |
Bone Marrow |
Allogeneic |
Chronic Granulomatous Disease |
Hematology |
2024 |
Standard Therapy |
Poland |
4 |
| 1466 |
Bone Marrow |
Allogeneic |
Chronic Granulomatous Disease |
Hematology |
2024 |
Standard Therapy |
Poland |
41 |
| 1467 |
Bone Marrow |
Allogeneic |
Chronic Lymphocytic Leukemia Richter Transformation |
Hematology |
2024 |
Standard Therapy |
Poland |
55 |
| 1468 |
Bone Marrow |
Allogeneic |
Chronic Myelogenous Leukemia |
Hematology |
2024 |
Standard Therapy |
Poland |
67 |
| 1469 |
Bone Marrow |
Allogeneic |
Chronic Myelogenous Leukemia |
Hematology |
2024 |
Standard Therapy |
Poland |
12 |
| 1470 |
Bone Marrow |
Allogeneic |
Diffuse Large B-Cell Lymphoma |
Hematology |
2024 |
Standard Therapy |
Poland |
61 |
| 1471 |
Bone Marrow |
Allogeneic |
Genetically Determined Thrombocytopenia |
Hematology |
2024 |
Standard Therapy |
Poland |
4 |
| 1472 |
Bone Marrow |
Allogeneic |
High Risk Acute Myeloid Leukaemia |
Hematology |
2024 |
Standard Therapy |
Poland |
13 |
| 1473 |
Bone Marrow |
Allogeneic |
Hodgkin Lymphoma |
Hematology |
2024 |
Standard Therapy |
Poland |
32 |
| 1474 |
Bone Marrow |
Allogeneic |
Inherited Metabolic Disease |
Hematology |
2024 |
Standard Therapy |
Poland |
11 |
| 1475 |
Bone Marrow |
Allogeneic |
Mds-Rcc Relapse |
Hematology |
2024 |
Standard Therapy |
Poland |
14 |
| 1476 |
Bone Marrow |
Allogeneic |
Mixed Cellularity Hodgkin Lymphoma |
Hematology |
2024 |
Standard Therapy |
Poland |
43 |
| 1477 |
Bone Marrow |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2024 |
Standard Therapy |
Poland |
14 |
| 1478 |
Bone Marrow |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2024 |
Standard Therapy |
Poland |
8 |
| 1479 |
Bone Marrow |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2024 |
Standard Therapy |
Poland |
14 |
| 1480 |
Bone Marrow |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2024 |
Standard Therapy |
Poland |
67 |
| 1481 |
Bone Marrow |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2024 |
Standard Therapy |
Poland |
9 |
| 1482 |
Bone Marrow |
Allogeneic |
Osteopetrosis type B |
Hematology |
2024 |
Standard Therapy |
Poland |
13 |
| 1483 |
Bone Marrow |
Allogeneic |
Other Leukemia |
Hematology |
2024 |
Standard Therapy |
Poland |
9 |
| 1484 |
Bone Marrow |
Allogeneic |
Primary Immunodeficiency |
Hematology |
2024 |
Standard Therapy |
Poland |
7 |
| 1485 |
Bone Marrow |
Allogeneic |
Primary Immunodeficiency Xlp-1 |
Hematology |
2024 |
Standard Therapy |
Poland |
18 |
| 1486 |
Bone Marrow |
Allogeneic |
Relapse T-Acute Lymphoblastic Leukemia |
Hematology |
2024 |
Standard Therapy |
Poland |
12 |
| 1487 |
Bone Marrow |
Allogeneic |
Secondary Acute Myelogenous Leukemia |
Hematology |
2024 |
Standard Therapy |
Poland |
4 |
| 1488 |
Bone Marrow |
Allogeneic |
Secondary Acute Myelogenous Leukemia |
Hematology |
2024 |
Standard Therapy |
Poland |
15 |
| 1489 |
Bone Marrow |
Allogeneic |
Severe Aplastic Anemia |
Hematology |
2024 |
Standard Therapy |
Poland |
7 |
| 1490 |
Bone Marrow |
Allogeneic |
Severe Aplastic Anemia |
Hematology |
2024 |
Standard Therapy |
Poland |
3 |
| 1491 |
Bone Marrow |
Allogeneic |
Severe Aplastic Anemia |
Hematology |
2024 |
Standard Therapy |
Poland |
10 |
| 1492 |
Bone Marrow |
Allogeneic |
Severe Aplastic Anemia |
Hematology |
2024 |
Standard Therapy |
Poland |
21 |
| 1493 |
Bone Marrow |
Allogeneic |
Severe Aplastic Anemia |
Hematology |
2024 |
Standard Therapy |
Poland |
18 |
| 1494 |
Bone Marrow |
Allogeneic |
Severe Aplastic Anemia |
Hematology |
2024 |
Standard Therapy |
Poland |
49 |
| 1495 |
Bone Marrow |
Allogeneic |
Severe Aplastic Anemia |
Hematology |
2024 |
Standard Therapy |
Poland |
16 |
| 1496 |
Bone Marrow |
Allogeneic |
Severe Aplastic Anemia |
Hematology |
2024 |
Standard Therapy |
Poland |
24 |
| 1497 |
Bone Marrow |
Allogeneic |
Severe Aplastic Anemia |
Hematology |
2024 |
Standard Therapy |
Poland |
13 |
| 1498 |
Bone Marrow |
Allogeneic |
Severe Aplastic Anemia |
Hematology |
2024 |
Standard Therapy |
Poland |
14 |
| 1499 |
Bone Marrow |
Allogeneic |
Severe Aplastic Anemia |
Hematology |
2024 |
Standard Therapy |
Poland |
21 |
| 1500 |
Bone Marrow |
Allogeneic |
Severe Aplastic Anemia |
Hematology |
2024 |
Standard Therapy |
Poland |
7 |